Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment
Hannah Gordon, Silvia Minozzi, Uri Kopylov, et al.
Journal of Crohn s and Colitis (2024)
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment
Michel Adamina, Silvia Minozzi, Janindra Warusavitarne, et al.
Journal of Crohn s and Colitis (2024)
Open Access | Times Cited: 23
Understanding the therapeutic toolkit for inflammatory bowel disease
Sophie Vieujean, Vipul Jairath, Laurent Peyrin‐Biroulet, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 2
Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU
Lucía Madero‐Velazquez, Alejandro Mínguez, L Mayorga, et al.
United European Gastroenterology Journal (2025)
Open Access | Times Cited: 1
Inflammatory bowel disease in south Asia: a scoping review
Smita Shenoy, Anuraag Jena, Carrie Levinson, et al.
˜The œLancet. Gastroenterology & hepatology (2025) Vol. 10, Iss. 3, pp. 259-274
Closed Access | Times Cited: 1
Anwendung fortgeschrittener Therapien bei chronisch-entzündlichen Darmerkrankungen
Benjamin Misselwitz, Sebastian Zeißig, Stefan Schreiber, et al.
Deleted Journal (2025)
Open Access
Operative Management of Small and Large Bowel Crohn’s Disease
Imran Khan, Stefan D. Holubar
Surgical Clinics of North America (2025) Vol. 105, Iss. 2, pp. 247-276
Closed Access
Exploring Chemoprevention in Colorectal Cancer for Patients with Inflammatory Bowel Disease: Mechanisms of Action and Clinical Aspects
Fotios S. Fousekis, Konstantinos Mpakogiannis, Panagiotis Filis, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 229-229
Open Access
Meta‐Analysis: Exclusive Enteral Nutrition in Adults With Ulcerative Colitis
Matthew Chu, Alice S. Day, Lani Broad, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access
Combining Advanced Targeted Therapy in Inflammatory Bowel Disease: Current Practice and Future Directions
A. De Bernardi, Cristina Bezzio, Michele Puricelli, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 590-590
Open Access
Mesalazine alleviated the symptoms of spontaneous colitis in interleukin-10 knockout mice by regulating the STAT3/NF-κB signaling pathway
Qian Chen, Yali Zhang, Yongquan Shi, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 7
Closed Access
A Treat-to-Target Approach in IBD: Contemporary Real-World Perspectives from an International Survey
Mohmmed Tauseef Sharip, Biljana Brezina, Juan De La Revilla Negro, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 667-667
Open Access
MRI Volumetric Changes in Perianal Fistulizing Crohn's Disease: Moving Toward a Novel Outcome Measure for Therapeutic Response
Raja Atreya, Markus F. Neurath
United European Gastroenterology Journal (2025)
Open Access
Dual Therapy in Inflammatory Bowel Disease
Gabriele Altieri, Alessandra Zilli, Tommaso Lorenzo Parigi, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 222-222
Open Access
Melezitose inhibited glycolytic pathway and enhances anti-Crohn's disease activity via binding to PGK1
Miaomiao Zhang, Jianing Ma, Shulipan Mulati, et al.
Journal of Ethnopharmacology (2025), pp. 119443-119443
Open Access
Early Ustekinumab Use Improves Clinical Outcomes in Biologic-Naive Crohn’s Disease Patients: A Retrospective Multicenter Cohort Study in Taiwan
Yen‐Cheng Chang, Chiao‐Hsiung Chuang, Tien‐Yu Huang, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 391-391
Open Access
Mistakes to avoid in the management of abdominal tuberculosis
Abhirup Chatterjee, Daya Krishna Jha, Aravind Sekar, et al.
Expert Review of Anti-infective Therapy (2025)
Closed Access
The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease
Konika Sharma, Brad W. deSilva, Stephen B. Hanauer
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Temporal Trends in the Use of Biological Agents in Patients with Inflammatory Bowel Disease: Real-World Data from a Tertiary Inflammatory Bowel Disease Greek Center During a 5-Year Period
Panagiotis Markopoulos, Aikaterini Gaki, Georgios Kokkotis, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1357-1357
Open Access
Advanced Combination Therapy with Biologics and Upadacitinib in Refractory Inflammatory Bowel Disease: A Retrospective Study from Taiwan
Ming-Jung Meng, Chia‐Jung Kuo, Ming-Wei Lai, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2733-2742
Open Access
Tryptophan metabolites profile predict remission with dietary therapy in pediatric Crohn’s disease
Rotem Sigall Boneh, Nikki van der Kruk, Eytan Wine, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
Treatment sequencing in inflammatory bowel disease : towards clinical precision medicine
Léa Sequier, Bénédicte Caron, Sailish Honap, et al.
Best Practice & Research Clinical Gastroenterology (2025), pp. 101994-101994
Closed Access
Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis
Nouran Alwisi, Rana Ismail, H. Al-Saad Al-Kuwari, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 702-702
Open Access
Risk factors for humanized IgG1 monoclonal antibody in the treatment of Crohn's disease: pharmacovigilance of the FDA adverse event reporting system (FAERS)
Jiangchuan Xie, Chun Tao, Linli Xie, et al.
Research Square (Research Square) (2025)
Closed Access
Patient experiences with and adherence to Crohn’s disease exclusion diet in Dutch Crohn’s disease patients: a cohort study
Fleur T. R. Wijers, Suzanne M.C. van Zundert, Charlotte M. Verburgt, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
Persistence and Efficacy of Ustekinumab in Crohn’s Disease After Anti-TNF Failure: An Observational Study
I. Latras-Cortés, J. C. Sáez Hortelano, Patricia Suárez-Álvarez, et al.
Digestive Diseases and Sciences (2025)
Closed Access
Page 1 - Next Page

Scroll to top